An Evaluation of Cabozantinib for the Treatment of Renal Cell Carcinoma: Focus on Patient Selection and Perspectives

Iaxx R, Lefort F, Domblides C, Ravaud A, Bernhard JC, Gross-Goupil M

Therapeutics and Clinical Risk Management 2022, 18:619-632

Published Date: 2 June 2022